Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organismsJames A. Retsema, Rachel J. Mason, Agnès Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 461
CP-45,899, a Beta-Lactamase Inhibitor That Extends the Antibacterial Spectrum of Beta-Lactams: Initial Bacteriological CharacterizationA. R. English, Wayne E. Barth, James A. Retsema et al.|Antimicrobial Agents and Chemotherapy|1978Cited by 397
<b>Molecular cloning and functional analysis of a novel macrolide‐resistance determinant, <i>mefA</i>, from <i>Streptococcus pyogenes</i></b>Joanna Clancy, James A. Retsema, J.W. Petitpas et al.|Molecular Microbiology|1996Cited by 360
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distributionAgnès Girard, James A. Retsema, D Girard et al.|Antimicrobial Agents and Chemotherapy|1987Cited by 323
Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; A new class of macrolide antibiotics, the azalides.G. Michael Bright, Rachel J. Mason, A. Nagel et al.|The Journal of Antibiotics|1988Cited by 238